GenomOncology Pathology Workbench to Support OmniSeq INSIGHT℠, a Genomic and Immune Profiling Test That Identifies Potential Treatment and Clinical Trial Options for Solid TumorsPRNewsWire • 01/12/22
LABORATORY CORPORATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Laboratory Corporation of America Holdings on Behalf of Laboratory Corporation Stockholders and Encourages Investors to Contact the FirmBusiness Wire • 01/11/22
Labcorp to Announce Fourth Quarter and Full Year 2021 Financial Results on February 10, 2022Business Wire • 01/10/22
SHAREHOLDER ALERT: Robbins LLP Investigates Laboratory Corporation of America Holdings (LH) on Behalf of ShareholdersBusiness Wire • 01/10/22
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Laboratory Corporation of America Holdings (LH) on Behalf of InvestorsBusiness Wire • 01/06/22
The Law Offices of Frank R. Cruz Announces Investigation of Laboratory Corporation of America Holdings (LH) on Behalf of InvestorsBusiness Wire • 01/06/22
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Laboratory Corporation of America Holdings (LH) on Behalf of InvestorsBusiness Wire • 01/05/22
Labcorp to Speak Virtually at the 40th Annual J.P. Morgan Healthcare ConferenceBusiness Wire • 01/04/22
Labcorp Strengthens Oncology Leadership Position With the Addition of Personal Genome Diagnostics, a Provider of Comprehensive Liquid Biopsy and Tissue-Based Genomic Products and ServicesBusiness Wire • 12/23/21
LabCorp (LH) Upgraded to Strong Buy: What Does It Mean for the Stock?Zacks Investment Research • 12/15/21
Laboratory Corp. to buy back $1 billion of stock in accelerated deal with Goldman, BarclaysMarket Watch • 12/14/21